Aarti Pharmalabs Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 56.11 | -100% | 0 | 0% |
| P/S |
|
0 | 17.79 | -100% |
|
|
| P/BV |
|
0 | 8.08 | -100% |
|
|
| P/FCF |
|
0 | -381.8 | -100% |
|
|
| Ev/Ebitda |
|
0 | 4.22 | -100% |
|
|
| Ev/S |
|
0 | 16.49 | -100% |
|
|
| Ev/FCF |
|
0 | -240.24 | -100% |
|
|
| E/P |
|
0 | 0.0159 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -18.77 | -100% | 0 | 0% |
| ROE |
|
0 | 3.69 | -100% |
|
|
| ROA |
|
0 | 3.44 | -100% |
|
|
| ROIC |
|
0 | 11.26 | -100% |
|
|
| ROS |
|
0 | -47.96 | -100% |
|
|
| ROCE |
|
0 | 5.09 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | 24.38 | -100% | 0 | 0% |
| Nеt Debt/Ebitda |
|
0 | 21.3 | -100% |
|
|
| Debt/Ratio |
|
0 | 0.126 | -100% |
|
|
| Debt/Equity |
|
0 | 4.64 | -100% |
|
|
| Debt/Net Income |
|
0 | -49.02 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
1.13/10
|
0.4452 | 0.6496 | -31.47% | 0.4452 | -0.0033% |
| Number of years of dividend growth |
|
1 | 0.92 | 8.7% | ||
| DSI |
|
0.8333 | 0.8171 | 1.98% |
|
|
| Average dividend growth |
|
-50 | 1.6 | -3227.55% |
|
|
| Average percentage for 5 years |
|
0.4452 | 0.8856 | -49.73% |
|
|
| Average percentage for payments |
|
0 | 22.22 | -100% |
|
|
| Difference from average difference in sector |
|
-0.2044 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | 72.87 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
0 | 72.97 | -100% | ||
| Growth impulse Net Income in 5 years |
|
0 | 159.06 | -100% | ||
| Growth impulse FCF in 5 years |
|
0 | 85.7 | -100% | ||
| Growth impulse EPS in 5 years |
|
0 | 104.61 | -100% |
IP Score
2.84/10
